Skip to main content
ALMR logo

Alamar Biosciences, Inc.

ALMRNASDAQHealthcareMedical Instruments & Supplies

$30.39Today:- (-)

As of Oct 26, 2026 close

Market cap
$1.78B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$18.85$39.61
Volume (live)
-
Avg. volume (3M)
742.78K

Alamar Biosciences (ALMR) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Alamar Biosciences had return on equity of -33.6%, debt-to-equity of 0.55 (up from 0.33), a current ratio of 3.99 (down from 6.43) and return on assets of -13.5%. A current ratio of 3.99 means current assets exceed current liabilities.

Alamar Biosciences Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income StatementBalance SheetCash FlowRatios
Scroll to see more
BreakdownFY 2025FY 2024
Period endingDec 2025Dec 2024
Valuation Ratios
Enterprise Value Ratios
Profitability & Returns
Return on Equity (ROE)-33.57%-
Return on Assets (ROA)-13.53%-
Return on Capital Employed (ROCE)-27.00%-37.30%
Leverage & Solvency Ratios
Debt/Equity0.550.33
Liquidity Ratios
Current Ratio3.996.43
Quick Ratio1.805.22
Efficiency Ratios
Asset Turnover0.51-
Inventory Turnover1.23-
Yield & Distribution Ratios
Buyback Yield2.89%-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Alamar Biosciences Financial Ratios

What is Alamar Biosciences's return on equity?

Alamar Biosciences's return on equity (ROE) was -33.6% for fiscal 2025 (period ended Dec 31, 2025).

What is Alamar Biosciences's debt-to-equity ratio?

Alamar Biosciences's debt-to-equity ratio was 0.55 for fiscal 2025 (period ended Dec 31, 2025). It was 0.33 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition